Characterization of CD4+ T Cell Subsets in Patients with Abdominal Aortic Aneurysms
Table 1
Demographic and clinical features of patients with AAA and controls.
Patients ()
Controls ()
Age (mean ± SD)
63.4 ± 13.2
60.6 ± 9
0.04
Sex (M/F)
28/2
6/5
0.009
Maximum aortic diameter (mean ± SD)
6.5 ± 1.6
—
—
Maximum thrombus thickness (mean ± SD)
2.8 ± 2.0
—
—
Comorbidities (%)
Diabetes
23.3
63.6
0.06
Dyslipidemia
20
63.6
0.07
Hypertension
70
81.8
1.0
Smoking history
80
54.6
0.69
Obesity
20
63.6
0.01
Medication (%)
β-Blockers
33.3
36.4
0.17
Aspirin
25
27.3
1.0
ACEI
45.8
36.4
0.68
Calcium blockers
12.5
18.2
0.5
Statins
25
72.8
0.001
Diuretics
20.8
36.4
0.06
Hypoglycemics
20.8
27.3
0.08
Other
33.3
36.4
1.0
Cardiovascular disease (%)
36.0
9.0
0.22
Biochemical parameters (mean ± SD)
ALT (U/l)
15.3 ± 9.6
31 ± 12.2
0.04
AST (U/l)
19.7 ± 4.3
21.4 ± 4.6
0.39
CR (mg/dl)
1.1 ± 0.3
0.85 ± 0.1
0.03
K (mEq/l)
4.7 ± 0.4
4.8 ± 0.4
0.75
Na (mEq/l)
141.4 ± 3.0
141.3 ± 4.2
0.96
U (mg/dl)
36.1 ± 9.7
32.8 ± 10.2
0.5
CRP (mg/l)
4.68 ± 3.3
2.49 ± 1.8
0.09
Continuous data are presented as mean (standard deviation) and analyzed by -test. Fisher’s exact test was used for the analyses of categorical variables. M: male; F: female; SD: standard deviation; ACEI: angiotensin-converting enzyme inhibitors; CAD: coronary artery disease; ALT: alanine aminotransferase; AST: aspartate aminotransferase; CR: creatinine; K: potassium; Na: sodium; U: urea; CRP: C-reactive protein.
